These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38294306)

  • 1. Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis.
    Patil R; Mukhida S; Ajagunde J; Khan U; Khan S; Gandham N; Vyawhare C; Das NK; Mirza S
    Future Microbiol; 2024 Mar; 19():297-305. PubMed ID: 38294306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning based predictive model and systems-level network of host-microbe interactions in post-COVID-19 mucormycosis.
    Verma A; Rathi B
    Microb Pathog; 2022 Jan; 162():105324. PubMed ID: 34861346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of COVID-19-associated rhino-orbito-cerebral mucormycosis caused by
    Erami M; Mirhendi H; Momen-Heravi M; Hezaveh SJH; Ahsaniarani AH; Sabet SS; Aboutalebian S
    Front Cell Infect Microbiol; 2022; 12():898477. PubMed ID: 36310874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021.
    Buil JB; van Zanten ARH; Bentvelsen RG; Rijpstra TA; Goorhuis B; van der Voort S; Wammes LJ; Janson JA; Melchers M; Heusinkveld M; Melchers WJG; Kuijper EJ; Verweij PE
    Euro Surveill; 2021 Jun; 26(23):. PubMed ID: 34114540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rhino-orbito-cerebral mucormycosis from dental origin: Case report].
    Bravo JH; Agudelo AM; Cortés A; Matta L
    Biomedica; 2018 Mar; 38(1):27-31. PubMed ID: 29668130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review.
    Balushi AA; Ajmi AA; Sinani QA; Menon V; Berieki ZA; Shezawi AA; Azri SA; Rashdi AA; Jardani AA; Baluki TA; Ghaithi SA; Reesi AA; Al-Za'abi AT; Al' Balushi MA; Maqbali TA
    Int J Infect Dis; 2022 Aug; 121():203-210. PubMed ID: 35533833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19.
    Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV
    An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of COVID-19-associated mucormycosis due to Lichtheimia ramosa.
    Aboutalebian S; Erami M; Momen-Heravi M; Charsizadeh A; Hezaveh SJH; Matini AH; Ahsaniarani AH; Fakhrehi M; Mirhendi H
    J Clin Lab Anal; 2023 Apr; 37(8):e24895. PubMed ID: 37183276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
    B H S; Bidkar V; Prathipati K; Dabhekar S; Selvaraj K; G D
    Cureus; 2024 Apr; 16(4):e59007. PubMed ID: 38800245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
    Kumar S; Kumar H; Mali M; Meena BL
    Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated mucormycosis in India: Why such an outbreak?
    Pasquier G
    J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.
    Radotra B; Challa S
    Curr Fungal Infect Rep; 2022; 16(4):206-220. PubMed ID: 36193101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [COVID-19-associated mucormycosis in ophthalmological practice in the Volgograd region].
    Ermilov VV; Smirnov AV; Dorofeev NA; Grigor'eva NV; Tarasova NV; Kushniruk PI; Karadzhe M; Barkanov VB; Chernetsky OA; Poplavsky AE; Nesterova AA; Lozovik VV; Somova VV
    Arkh Patol; 2022; 84(5):43-49. PubMed ID: 36178222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period.
    Cherian LM; Varghese L; Rupa V; Bright RR; Abraham L; Panicker R; R N; Peter J; Nayak A; Shyam A; Varghese GM; Manesh A; Karuppusami R; George K; George T; Lenin A; Hansdak SG; I R; Michael JS; Ninan M; Thomas M; Kurian R; Mammen S; Kurien R
    Rhinology; 2022 Dec; 60(6):427-434. PubMed ID: 36150158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.